Observational studyCancer biology & therapy2018

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Laura Pizzuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.